1 |
Wu, Z., Turner, D. R. and Oliveira, D. B. 2001. IL-4 gene expression up-regulated by mercury in rat mast cells: a role of oxidant stress in IL-4 transcription. Int. Immunol. 13, 297-304.
DOI
|
2 |
Weiss, D. L., Hural, J., Tara, D., Timmerman, L. A., Henkel, G. and Brown, M. A. 1996. Nuclear factor of activated T cells is associated with a mast cell interleukin 4 transcription complex. Mol. Cell Biol. 16, 228-235.
DOI
|
3 |
Winter, G. and Harris, W. J. 1993. Humanized antibodies. Immunol. Today 14, 243-246.
DOI
|
4 |
Shah, M. M., Miyamoto, Y., Yamada, Y., Yamashita, H., Tanaka, H., Ezaki, T., Nagai, H. and Inagaki, N. 2010. Orally supplemented lactobacillus acidophilus strain L-92 inhibits passive and active cutaneous anaphylaxis as well as 2,4-dinitroflurobenzene and mite fecal antigen induced atopic dermatitis-like skin lesions in mice. Microbiol. Immunol. 54, 523-533.
DOI
|
5 |
Sistek, D., Kelly, R., Wickens, K., Stanley, T., Fitzharris, P. and Crane, J. 2006. Is the effect of probiotics on atopic dermatitis confined to food sensitized children? Clin. Exp. Allergy 36, 629-633.
DOI
|
6 |
Reber, L., Vermeulen, L., Haegeman, G. and Frossard, N. 2009. Ser276 Phosphorylation of NF-kB p65 by MSK1 Controls SCF Expression in Inflammation. PLoS ONE 4, e4393.
DOI
|
7 |
Lee, H. Y., Kim, M. K., Park, K. S., Shin, E. H., Jo, S. H., Kim, S. D., Jo, E. J., Lee, Y. N., Lee, C., Baek, S. H. and Bae, Y. S. 2006. Serum amyloid A induces contrary immune responses via formyl peptide receptor-like 1 in human monocytes. Mol. Pharmacol. 70, 241-248.
|
8 |
Lee, J., Seto D. and Bielory, L. 2008. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. J. Allergy Clin. Immunol. 121, 116-121
DOI
|
9 |
Leung, D. Y. 1999. Pathogenesis of atopic dermatitis. J. Allergy Clin. Immunol. 104, 99-108.
DOI
|
10 |
Lewin, I., Nechushtan, H., Ke, Q. and Razin, E. 1993. Regulation of AP-1 expression and activity in antigen-stimulated mast cells: the role played by protein kinase C and the possible involvement of Fos interacting protein. Blood 82, 3745-3751.
|
11 |
Hatano, Y., Terashi, H., Arakawa, S. and Katagiri, K. 2005. Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis. J. Invest. Dermatol. 124, 786-792.
DOI
|
12 |
Hayashi, A., Kimura, M., Nakamura, Y. and Yasui, H. 2009. Anti-atopic dermatitis effects and the mechanism of lactic acid bacteria isolated from Mongolian fermented milk. J. Dairy Res. 76, 158-164.
DOI
|
13 |
Heyman, M., Terpend, K. and Menard, S. 2005. Effects of specific lactic acid bacteria on the intestinal permeability to macromolecules and the inflammatory condition. Acta Paediatr. Suppl. 94, 34-36
DOI
|
14 |
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P. and Isolauri, E. 2001. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357, 1076-1079.
DOI
|
15 |
Salek, M. S., Finlay, A. Y., Luscombe, D. K., Allen, B. R., Berth-Jones, J., Camp, R. D., Graham-Brown, R. A., Khan, G. K., Marks, R. and Motley, R. J. 1993. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. Br. J. Dermatol. 129, 422-430.
DOI
|
16 |
Sohn, E. H., Jang, S. A., Joo, H., Park, S., Kang, S. C., Lee, C. H. and Kim, S. Y. 2011 Anti-allergic and anti-inflammatory effects of butanol extract from Arctium Lappa L. Clin. Mol. Allergy 9, 4.
DOI
|
17 |
Thanos, D. and Maniatis, T. 1995. NF-kappa B: a lesson in family values. Cell 80, 529-532.
DOI
|
18 |
Watanabe, T., Hamada, K., Tategaki, A., Kishida, H., Kitano, M. and Miyamoto, T. 2009. Oral administration of lactic acid bacteria isolated from traditional south Asian fermented milk ‘dahi’ inhibits the development of atopic dermatitis in NC/Nga mice. J. Nutr. Sci. Vitaminol. (Tokyo) 55, 271-278
DOI
|
19 |
Liong, M. T. 2008. Roles of probiotics and prebiotics in colon cancer prevention: postulated mechanisms and in-vivo evidence. Int. J. Mol. Sci. 9, 854-863.
DOI
|
20 |
Masuda, A., Yoshikai, Y., Kume, H. and Matsuguchi, T. 2004. The interaction between GATA proteins and activator protein-1 promotes the transcription of IL-13 in mast cells. J. Immunol. 173, 5564-5573.
DOI
|
21 |
Matsubara, M., Masaki, S., Ohmori, K., Karasawa, A. and Hasegawa, K. 2004. Differential regulation of IL-4 expression and degranulation by anti-allergic olopatadine in rat basophilic leukemia (RBL_2H3) cells. Biochem. Pharmacol. 67, 1315-1326.
DOI
|
22 |
Nerlov, C. and Graf, T. 1998. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12, 2403-2412.
DOI
|
23 |
Khani, S., Hosseini, H. M., Taheri, M., Nourani, M. R. and Imani Fooladi, A. A. 2012. Probiotics as an alternative strategy for prevention and treatment of human diseases: areview. Inflamm. Allergy Drug Targets 11, 79-89.
DOI
|
24 |
Hirasawa, N., Sato, Y., Fujita, Y. and Ohuchi, K. 2000. Involvement of a phosphatidylinositol 3-kinase-p38 mitogen activated protein kinase pathway in antigen-induced IL-4 production in mast cells. Biochem. Biophys. Acta. 1456, 45-55.
|
25 |
Hirasawa, R., Shimizu, R., Takahashi, S., Osawa, M., Takayanagi, S., Kato, Y., Onodera, M., Minegishi, N., Yamamoto, M., Fukao, K., Taniguchi, H., Nakauchi, H. and Iwama, A. 2002. Essential and instructive roles of GATA factors in eosinophil development. J. Exp. Med. 195, 1379-1386.
DOI
|
26 |
Jo, Y. R. and Kang, S. M. 2012. Lactococcus lactis culture method for enhanced depression of inducer in atopic diseases. Kor. J. Microbiol. Biotechnol. 40, 310-318.
DOI
|
27 |
Beaulieu, J., Girad, D., Dupont, C. and Lemieux, P. 2009. Inhibition of neutrophil infiltration by a malleable protein matrix of lactic acid bacteria-fermented whey proteins in vivo. Inflamm. Res. 58, 133-138
DOI
|
28 |
Brockman, J. A., Scherer, D. C., McKinsey, T. A., Hall, S. M., Qi X., Lee, W. Y. and Ballard, D. W. 1995. Coupling of a signal response domain in I kappa B alpha to multiple pathways for NF-kappa B activation. Mol. Cell. Biol. 15, 2809-2818.
DOI
|
29 |
Finco, T. S. and Baldwin, A. S. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3, 263-272.
DOI
|
30 |
Burgos-Ramos, E., Canelles, S., Perianes, C. A., Arilla, F. E., Argente, J. and Barrios, V. 2012. Adipose tissue promotes a serum cytokine profile related to lower insulin sensitivity after chronic central leptin infusion. PLoS One 7, e46893.
DOI
|
31 |
Ooi, L. G. and Liong, M. T. 2010. Cholesterol-lowering effects of probiotics and prebiotkcs: A revkew of in vivo and in vitro findings. Int. J. Mol. Sci. 11, 2499-2522
DOI
ScienceOn
|
32 |
McNagny, K. and Graf, T. 2002. Making eosinophils through subtle shifts in transcription factor expression. J. Exp. Med. 195, 43-47.
DOI
|
33 |
Min, Y. D., Choi, C. H., Bark, H., Son, H. Y., Park, H. H., Lee, S., Park, J. W., Park, E. K., Shin, H. I. and Kim, S. H. 2007. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm. Res. 56, 210-215.
DOI
|
34 |
Moroi, M., Uchi, S., Nakamura, K., Sata, S., Shimizu, N., Fujji, M., Kumagai, T., Saito, M., Uchiyama, K., Watanabe, T., Yamaguchi, H., Yamamoto, T., Takeuchi, S. and Furue, M. 2011. Beneficial effect of a diet containing heat-killed Lactobacillus paracasei K71 on adult type atopic dermatitis. J. Dermatol. 38, 131-139
DOI
|
35 |
Kim, B. E., Leung, D. Y., Boguniewicz, M. and Howell, M. D. 2008. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin. Immunol. 126, 332-337.
DOI
|
36 |
Klein, M., Klein, H. S., Palmetshofer, A., Serfling, E., Tertilt, C., Bopp, T., Heib, V., Becker, M., Taube, C., Schild, H., Schmitt, E. and Stassen, M. 2006. Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines. J. Immunol. 177, 6667-6674.
DOI
|
37 |
Kurahashi, R., Hatano, Y. and Katagiri, K. 2008. IL-4 suppresses the recovery of cutaneous permeability barrier functions in vivo. J. Invest. Dermatol. 128, 1329-1331.
DOI
|
38 |
Leung, D. Y. and Soter, N. A. 2001. Cellular and immunologic mechanisms in atopic dermatitis. J. Am. Acad. Dermatol. 44, S1-S12.
DOI
ScienceOn
|
39 |
Crabtree, G. R. 1999. Generic signals and specific outcomes: signaling through Ca2+, calcineurin, and NF-AT. Cell 96, 611-614.
DOI
|
40 |
Chen, Z. J., Parent, L. and Maniatis, T. 1996. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84, 853-862.
DOI
|
41 |
Granlund, H., Erkko, P., Sinisalo, M. and Reitamo, S. 1995. Cyclosporin in atopic dermatitis: time to relapse and effect of intermittent therapy. Br. J. Dermatol. 132, 106-112.
DOI
|
42 |
Harigae, H., Takahashi, S., Suwabe, N., Ohtsu, H., Gu, L., Yang, Z., Tsai, F. Y., Kitamura, Y., Engel, J. D. and Yamamoto, M. 1998. Differential roles of GATA-1 and GATA-2 in growth and differentiation of mast cells. Genes Cells 3, 39-50.
DOI
|
43 |
Baeuerle, P. A. and Baltimore, D. 1996. NF-κB: ten years after. Cell 87, 13-20.
DOI
|
44 |
Albanesi, C., Fairchild, H. R., Madonna, S., Scarponi, C., De Pitá, O., Leung, D. Y. and Howell, M. D. 2007. IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J. Immunol. 179, 984-992.
DOI
|
45 |
Alkalay, I., Yaron, A., Hatzubai, A., Orian, A., Ciechanover, A. and Ben-Neriah, Y. 1995. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 92, 10599-10603.
DOI
|
46 |
Baeuerle, P. A. and Baltimore, D. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242, 540-546.
DOI
|